Suchergebnisse - "Myeloma"

PubPharm (2.206)

1

A survey of prognostic value of serum factors in multiple myeloma patients before treatment: macrophage-colony stimulating factor (M-CSF) is a powerful predictor of survival

enthalten in: Medical oncology | 2009

von Kowalska, M. | Kaminska, J. | Fuksiewicz, M. | +4

2

A survey of prognostic value of serum factors in multiple myeloma patients before treatment: macrophage-colony stimulating factor (M-CSF) is a powerful predictor of survival

enthalten in: Medical oncology | 2009

von Kowalska, M. | Kaminska, J. | Fuksiewicz, M. | +4

3

Methylation status of nine tumor suppressor genes in multiple myeloma

enthalten in: International journal of hematology | 2009

von Braggio, E. | Maiolino, A. | Gouveia, M. | +5

4

An unusual presentation of extramedullary plasmacytoma in testis and review of the literature

enthalten in: Medical oncology | 2009

von Turk, H. | Komurcu, S. | Ozet, A. | +2

5

Treatment of newly diagnosed multiple myeloma: advances in current therapy

enthalten in: Medical oncology | 2009

von Kumar, S.

6

An unusual presentation of extramedullary plasmacytoma in testis and review of the literature

enthalten in: Medical oncology | 2009

von Turk, H. | Komurcu, S. | Ozet, A. | +2

7

Treatment of newly diagnosed multiple myeloma: advances in current therapy

enthalten in: Medical oncology | 2009

von Kumar, S.

8

A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma : "Phase II Multicenter, Open-Label, Clinical and Pharmacokinetic Study of Aplidin® As A 3-Hour Infusion Every 2 Weeks Alone or in Combination With Dexamethasone, in Pre-Treated Patients With Relapsing or Refractory Multiple Myeloma."

enthalten in: ClinicalTrials.gov | 2009

9

Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked

enthalten in: Cancer immunology immunotherapy | 2009

von von Lilienfeld-Toal, M. | Frank, S. | Leyendecker, C. | +8

10

Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked

enthalten in: Cancer immunology immunotherapy | 2009

von von Lilienfeld-Toal, M. | Frank, S. | Leyendecker, C. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[221]